Company: BDRX
Filing Date: 2025-12-08
Form Type: F-1/A
Source: 0001214659-25-017719
Chunk: 6

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-12-08
Form: F-1/A
Chunk 6
---
 discount to the current
market price. Therefore, the assumed combined public offering price used throughout this
prospectus may not be indicative of the final public offering price.

The Units have no stand-alone
rights and will not be certificated or issued as stand-alone securities.

There is no established trading
market for the Units, Pre-Funded Units, Series L Warrants or Pre-Funded Warrants, and we do not expect a market to develop. In addition,
we do not intend to apply for the listing of the Pre-Funded Warrants or Series L Warrants on any national securities exchange or other
trading market. Without an active trading market, the liquidity of these securities will be limited.

This offering will terminate
no later than fifteen (15) business days following the effectiveness of this prospectus, unless we decide to terminate the offering (which
we may do at any time in our discretion) prior to such date.

<div align='center'>___________________</div>

We
have engaged Maxim Group LLC as our exclusive placement agent, or Maxim or the placement
agent, to use its reasonable best efforts to solicit offers to purchase our securities in
this offering. The placement agent is not purchasing or selling any of the securities we
are offering and the placement agent is not required to arrange the purchase or sale of any
specific number or dollar amount of securities. There is no required minimum number of securities
that must be sold as a condition to closing this offering. Because there is no minimum offering
amount required as a condition to closing in this offering the actual public amount, placement
agent’s fee, and proceeds to us, if any, are not presently determinable and may be
substantially less than the total maximum offering amounts set forth above and throughout
this prospectus. Investors in this offering will not receive a refund if we do not sell all
of the securities offered hereby. There is no arrangement for funds to be received in escrow,
trust or similar arrangement and the Depositary Shares (or Pre-Funded Warrants in lieu thereof)
will be offered at a fixed price and are expected to be issued in a single closing. We have
agreed to pay the placement agent the placement agent fees set forth in the table below.

|                                  |     |   | Per  
 Unit |     |   | Per        
 Pre-Funded 
 Unit       |     |   | Total |
|:---------------------------------|:----|:--|:-----|:----|:--|:-----------